Thomson Reuters debuts infection tracking dashboard
Thomson Reuters of Ann Arbor, Mich., has launched the Infection Xpert, a clinical intelligence dashboard to help manage and reduce hospital-acquired infections (HAI), capture and submit mandated infection reporting metrics, as well as analyze hospital infection data.
The following information and functionality is delivered on the dashboard:
The technology uses evidence-based clinical decision support (CDS) rules to identify medical risks early. For example, the system identifies patients exhibiting signs of a serious infection and in need of immediate attention.
More than 70 hospitals use the technology to monitor patients in real-time for high-risk conditions. The technology includes a library of pre-built CDS rules developed using Micromedex evidence-based reference processes. These rules cover categories, such as multi-drug resistant organisms, clostridium difficile infection, methicillin-resistant staphylococcus aureus infection, and CDC-defined HAIs, such as central line-associated bloodstream infection.
Using aggregated data from disparate information systems throughout the hospital, the technology gives infection preventionalists a single view of comprehensive data about patients, including critical lab values, medication lists, vital signs, microbiology reports, demographics, transcribed reports and more. IPs can submit, collect and report National Healthcare Safety Network event and denominator data.
The following information and functionality is delivered on the dashboard:
- Surveillance of real-time clinical data to identify patients at risk of or with a new infection;
- Collection and reporting of data about CDC-defined HAI events;
- Data visualizations; and
- Integrated, patient-specific Micromedex clinical reference content.
The technology uses evidence-based clinical decision support (CDS) rules to identify medical risks early. For example, the system identifies patients exhibiting signs of a serious infection and in need of immediate attention.
More than 70 hospitals use the technology to monitor patients in real-time for high-risk conditions. The technology includes a library of pre-built CDS rules developed using Micromedex evidence-based reference processes. These rules cover categories, such as multi-drug resistant organisms, clostridium difficile infection, methicillin-resistant staphylococcus aureus infection, and CDC-defined HAIs, such as central line-associated bloodstream infection.
Using aggregated data from disparate information systems throughout the hospital, the technology gives infection preventionalists a single view of comprehensive data about patients, including critical lab values, medication lists, vital signs, microbiology reports, demographics, transcribed reports and more. IPs can submit, collect and report National Healthcare Safety Network event and denominator data.